Artificial Intelligence in Pharmacy: Applications in Drug Discovery and Clinical Decision Support Systems

Authors

  • Bhumi Sonare,Dr. Mamta Yadav

Keywords:

Artificial intelligence, pharmacy, drug discovery, clinical decision support system

Abstract

Artificial intelligence (AI) transforms pharmacy by improving the speed, precision, and evidence base of pharmaceutical research and clinical practice. In drug discovery, AI assists in target identification, virtual screening, molecular docking, lead optimization, toxicity prediction, pharmacokinetic modeling, drug repurposing, and personalized drug development. In clinical decision support systems (CDSSs), AI supports diagnosis, therapy selection, drug-drug interaction alerts, medication error reduction, risk prediction, and patient-specific pharmaceutical care. The aim of this thesis is to describe the concept of AI in pharmacy and to examine its applications in drug discovery and clinical decision support systems. The thesis is based on a narrative review of scientific literature, regulatory documents, and healthcare technology reports. The study highlights that AI can reduce research time, improve decision-making, enhance patient safety, and support precision medicine; however, issues such as data quality, algorithmic bias, privacy, explainability, regulatory validation, and human oversight remain important. The conclusion of this thesis is that AI should not replace pharmacists or clinicians but should act as a decision-support tool that strengthens evidence-based pharmaceutical care. Future pharmacy practice will require pharmacists who understand digital health, data science, pharmacovigilance, ethics, and AI-assisted clinical reasoning.

References

World Health Organization. Ethics and governance of artificial intelligence for health. Geneva: World Health Organization; 2021.

U.S. Food and Drug Administration. Artificial Intelligence for Drug Development [Internet]. Silver Spring: FDA; content current 2026 May 1 [cited 2026 May 8]. Available from:https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/artificial-intelligence-drug-development

U.S. Food and Drug Administration. Using artificial intelligence and machine learning in the development of drug and biological products: discussion paper. Silver Spring: FDA; 2023, revised 2025.

Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021;26(1):80-93.

Serrano DR, Luciano FC, Anaya BJ, et al. Artificial intelligence applications in drug discovery and the pharmaceutical industry. Pharmaceutics. 2024;16:1-28.

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589.

Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493-500.

Graafsma J, Heringa M, Gebuis E, et al. The use of artificial intelligence to optimize medication alerts in clinical decision support systems: a systematic review. Int J Med Inform. 2024;185:105387.

Armando LG, et al. Clinical decision support systems to improve drug prescription and to reduce medication errors: a systematic review. BMC Med Inform Decis Mak. 2023;23:1-15.

Shahmoradi L, Safdari R, Ahmadi H, Zahmatkeshan M. Clinical decision support systems-based interventions to improve medication safety: a systematic review on features and effects. J Biomed Inform. 2021;117:103759.

Syrowatka A, Song W, Amato MG, et al. Computerized clinical decision support to prevent medication errors and adverse drug events. In: Making Healthcare Safer IV. Rockville: Agency for Healthcare Research and Quality; 2024.

Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56.

Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347-1358.

Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24-29.

Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-477.

Schneider G. Automating drug discovery. Nat Rev Drug Discov. 2018;17(2):97-113.

Zhavoronkov A, Vanhaelen Q, Oprea TI. Will artificial intelligence for drug discovery impact clinical pharmacology? Clin Pharmacol Ther. 2020;107(4):780-785.

Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discov Today. 2019;24(3):773-780.

Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94-98.

Chen JH, Asch SM. Machine learning and prediction in medicine: beyond the peak of inflated expectations. N Engl J Med. 2017;376(26):2507-2509.

Downloads

How to Cite

Bhumi Sonare,Dr. Mamta Yadav. (2026). Artificial Intelligence in Pharmacy: Applications in Drug Discovery and Clinical Decision Support Systems. International Journal of Research & Technology, 14(2), 755–765. Retrieved from https://ijrt.org/j/article/view/1339

Issue

Section

Original Research Articles

Similar Articles

<< < 16 17 18 19 20 21 22 23 24 25 > >> 

You may also start an advanced similarity search for this article.